May 18, 2026 — AstraZeneca’s Baxfendy (baxdrostat) has been approved in the U.S. as a first-in-class aldosterone synthase inhibitor (ASI) for treating hypertension in combination with other ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
-
-
Editor's Note: This is Part Three of a three-part series highlighting several of the presentations from the American College of Cardiology’s Annual Scientific Session (ACC.26) that took place in March ...
-
May 1, 2026 — On May 14, Cleerly and interventional cardiologist Neerav Sheth, MD, will present a free webinar on "Plaque-Informed Ischemia: A New Paradigm for Vessel-Specific Risk Assessment." The ...
-
May 10, 2026 — Results from the first randomized trial evaluating microRNA inhibition in heart failure were presented today in Barcelona at Heart Failure 2026,1 the annual congress of the Heart ...
May 18, 2026 — AstraZeneca’s Baxfendy (baxdrostat) has been approved in the U.S. as a first-in-class aldosterone ...
May 18, 2026
May 13, 2026 — According to a recently released report, the global cath lab services market was valued at $46.0 billion ...
May 13, 2026
Feature | Heart Failure | Kyle Hardner
Editor's Note: This is Part Three of a three-part series highlighting several of the presentations from the American ...
May 13, 2026
May 12, 2026
May 10, 2026 — Results from the first randomized trial evaluating microRNA inhibition in heart failure were presented ...
May 11, 2026
May 1, 2026 — Echo IQ recently announced it has deployed its AI-based decision support software for the assessment of ...
May 07, 2026
May 7, 2026 — Bayer has announced positive topline results from the Phase III REVEAL study, an investigator-initiated ...
May 07, 2026
May 1, 2026 — Retia Medical recently announced the first public presentation of results from its non-invasive cardiac ...
May 07, 2026
Feature | Heart Failure | Kyle Hardner
Could a link between the heart, brain and immune system help reduce the occurrence of heart attacks and lessen the ...
May 04, 2026
Feature | FFR Technologies | Kyle Hardner
Editor's Note: This is Part Two of a three-part series highlighting several of the presentations from the American ...
April 30, 2026
April 26, 2026 — New results from the multicenter catheter ablation versus anti-arrhythmic drugs for Ventricular ...
April 29, 2026
April 24, 2026 — University of Texas Health Science Center at Houston (UTHealth Houston) has established the Department ...
April 28, 2026
April 27, 2026 — Banner Health recently announced it has reached a major milestone completing more than 50 total ...
April 28, 2026
April 26, 2026 – New results from the pivotal multicenter trial FULCRUM-VT show that ultra-low temperature ablation ...
April 27, 2026
April 24, 2026 – A novel detection algorithm spotted moderate-to-severe aortic stenosis (AS) with a sensitivity of 90.5% ...
April 24, 2026